KLK4 and colorectal carcinoma: Together with CEA and CA 19–9, these three metabolites (hydroquinone, sphingomyelin and mimosine and) and two proteins (coagulation factor XIII A chain and plasma kallikrein) are potential biomarkers, to improve the accuracy of diagnosis and monitoring of CRC.